Used in research and development for targeting heparin-binding epidermal growth factor-like growth factor (HB-EGF), this antibody serves as a critical tool in studying cellular proliferation, differentiation, and tissue regeneration. It is applied in oncology research, particularly in cancers where HB-EGF overexpression is linked, such as ovarian, breast, and bladder cancers. The antibody enables precise detection and neutralization of HB-EGF activity in cell-based assays and animal models, supporting the development of targeted therapies. It is also utilized in immunoassays and flow cytometry to quantify HB-EGF expression in various biological samples.